Baumann, Stefan, Becher, Tobias, Giannakopoulos, Konstantinos, Jabbour, Claude, Rutsch, Marlon, Fastner, Christian, El-Battrawy, Ibrahim, Ansari, Uzair, Lossnitzer, Dirk, Behnes, Michael, Alonso, Angelika, Kirschning, Thomas, Michels, Guido, Stern, Daniel, Dissmann, Ruediger, Kueck, Olaf, Taccone, Fabio Silvio, Waldmann, Carl, Bunker, Nicholas, Postiglione, Maurizio, Borggrefe, Martin and Akina, Ibrahim (2018). Bedside implantation of a new temporary vena cava inferior filter - Safety and efficacy results of the European ANGEL-Registry. J. Crit. Care, 44. S. 39 - 45. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1557-8615

Full text not available from this repository.

Abstract

Purpose: Pulmonary embolism (PE) is a frequently occurring complication in critically ill patients. Simultaneous occurrence of PE and life-threatening bleeding, may render medical anticoagulation impossible. For these patients, inferior vena cava filters (IVCF) present a valuable therapeutic alternative. The Angel (R) catheter is a novel IVCF that provides temporary protection from PE and is implanted at bedside. The primary objective of the European Angel (R) catheter registry is to evaluate the safety and efficacy of this IVCF. Material and methods: The European Angel (R) catheter registry is an observational, multi-centre registry. Patients from four countries and eight sites that have undergone Angel (R) catheter implantation between March 2013 and February 2017 were enrolled. Results: A total of 114 critically ill patients were included. The main indication for implantation was a high-risk for PE in combination with contraindications for anticoagulation (69.3%). One clinically non-significant PE (0.9%) occurred in a patient with an indwelling Angel (R) catheter. No cases of catheter associated serious complications were observed. Conclusion: Data shows that the Angel (R) catheter is a safe and effective approach to overcome the acute phase of critically ill patients with a high risk for the development of PE or an established PE, when an anticoagulation therapy is contraindicated. (C) 2017 Elsevier Inc. All rights reserved.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Baumann, StefanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Becher, TobiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Giannakopoulos, KonstantinosUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jabbour, ClaudeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rutsch, MarlonUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fastner, ChristianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
El-Battrawy, IbrahimUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ansari, UzairUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lossnitzer, DirkUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Behnes, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Alonso, AngelikaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kirschning, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Michels, GuidoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stern, DanielUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dissmann, RuedigerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kueck, OlafUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Taccone, Fabio SilvioUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Waldmann, CarlUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bunker, NicholasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Postiglione, MaurizioUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Borggrefe, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Akina, IbrahimUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-192186
DOI: 10.1016/j.jcrc.2017.10.009
Journal or Publication Title: J. Crit. Care
Volume: 44
Page Range: S. 39 - 45
Date: 2018
Publisher: W B SAUNDERS CO-ELSEVIER INC
Place of Publication: PHILADELPHIA
ISSN: 1557-8615
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
CRITICALLY-ILL PATIENTS; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; VENOUS THROMBOEMBOLISM; MEDICAL PATIENTS; PREVENTION; MANAGEMENT; SURVIVAL; TRIAL; RISKMultiple languages
Critical Care MedicineMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/19218

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item